+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Global CRISPR Technology Market 2019-2025

  • ID: 4863382
  • Report
  • October 2019
  • Region: Global
  • Orion Market Research Private Limited


  • AstraZeneca PLC
  • Beam Therapeutics Inc.
  • Cellectics SA
  • CRISPR Therapeutics AG
  • Editas Medicine
  • GenScript Biotech Corp.
CRISPR Technology Market Size, Share & Trends Analysis Report, By Application (Biomedical Applications, Agricultural Applications, and Industrial Applications), By End-User (Pharmaceutical & Biopharmaceutical Companies and Academic & Research Institutes), and Forecast 2019-2025.

The global CRISPR technology market is expected to witness a significant growth rate during the forecast period. CRISPR technology enables the alteration of DNA sequences and modifies the gene function. CRISPR technology can be used for various applications such as treatment of diseases, correcting gene, crop modification, bio-fuel manufacturing and many more. Industry giants are working in CRISPR technology development and are investing in the R&D of the technology. Such investments are expected to create an opportunity for the growth of the market in the near future.

The global CRISPR technology market is segmented on the basis of application and end-user. Based on the application, the market is segmented into biomedical applications, agricultural applications, and industrial applications. In fruit crops, CRISPR technology has numerous applications as it improves the important agronomic traits such as biotic and abiotic stress tolerance and fruit quality. Further, on the basis of end-user, the market is segmented into pharmaceutical & biopharmaceutical companies, and academic & research institutes. CRISPR being a really new technology seeks the interest of everyone from doctors to academic & research institutes. CRISPR holds a lot of hidden potentials to cure many rare and incurable diseases that are still to be discovered and is driving the academic & research institutes as an end-user segment to grow with a significant rate in the market.

Geographically, the market is segmented into four major regions; North America, Europe, Asia-Pacific and Rest of the world (RoW). Among these, North America is expected to hold a prominent position in the global CRISPR technology market. The presence of major pharma companies in the region tends to enhance the growth of the global CRISPR market. Further, the report covers the analysis of several players operating in the market. Some of the players include Thermo Fisher Scientific Inc., Merck KGaA, GenScript Biotech Corp., Horizon Discovery Group PLC, CRISPR Therapeutics AG, and others.

Research Methodology

The market study of the CRISPR market is incorporated by extensive primary and secondary research . Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. the research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. the analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.

The report is intended for CRISPR technology providers, end-user industries, existing companies, and new entrants into the market, potential investors and venture capitalists, government organizations and regulatory agencies, academic and research institutes, and other market participants for overall market analysis and competitive analysis. The report provides an in-depth analysis on market size, products offered by the company and future market opportunities. The report will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for making better business decisions.

Market Segmentation

1. Global CRISPR Technology Market Research and Analysis by Application
2. Global CRISPR Technology Market Research and Analysis by End-User

The Report Covers
  • Comprehensive research methodology of the global CRISPR technology market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global CRISPR technology market.
  • Insights about market determinants which are stimulating the global CRISPR technology market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown


  • AstraZeneca PLC
  • Beam Therapeutics Inc.
  • Cellectics SA
  • CRISPR Therapeutics AG
  • Editas Medicine
  • GenScript Biotech Corp.

1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Thermo Fisher Scientific, Inc. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.2. Merck KGaA Overview Financial Analysis SWOT Analysis Recent Developments
3.3.3. GenScript Biotech Corp. Overview Financial Analysis SWOT Analysis Recent Developments
3.3.4. Horizon Discovery Group PLC Overview Financial Analysis SWOT Analysis Recent Developments
3.3.5. CRISPR Therapeutics AG Overview Financial Analysis SWOT Analysis Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. CRISPR Technology Market by Application
5.1.1. Biomedical Applications
5.1.2. Agricultural Applications
5.1.3. Industrial Applications
5.2. Global CRISPR Technology Market by End-User
5.2.1. Pharmaceutical and Biopharmaceutical Companies
5.2.2. Academic & Research Institutes
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AstraZeneca PLC
7.2. BASF SE
7.3. Beam Therapeutics Inc.
7.4. Bio-Rad Laboratories, Inc.
7.5. Caribou Bioscience Inc.
7.6. Cellectics SA
7.7. Cibus, Ltd.
7.8. CRISPR Therapeutics AG
7.9. Danaher Corp.
7.10. Editas Medicine
7.11. GeneCopoeia inc.
7.12. GenScript Biotech Corp.
7.13. Horizon Discovery Group PLC
7.14. Intellia Therapeutics Inc.
7.15. Lonza Group Ltd.
7.16. Merck KGaA
7.17. New England Biolabs, Inc.
7.18. Origene Technologies, Inc.
7.19. Pairwise Plants
7.20. Precision Bioscience, Inc.
7.21. Sangamo Therapeutics Inc.
7.22. Thermo Fisher Scientific, Inc.
7.23. Transposagen Biopharmaceuticals, Inc.
7.24. Tropic Biosciences UK LTD.
7.25. Yield10 Bioscience, Inc.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AstraZeneca PLC
  • Beam Therapeutics Inc.
  • Bio-Rad Laboratories, Inc.
  • Caribou Bioscience Inc.
  • Cellectics SA
  • Cibus, Ltd.
  • CRISPR Therapeutics AG
  • Danaher Corp.
  • Editas Medicine
  • GeneCopoeia inc.
  • GenScript Biotech Corp.
  • Horizon Discovery Group PLC
  • Intellia Therapeutics Inc.
  • Lonza Group Ltd.
  • Merck KGaA
  • New England Biolabs, Inc.
  • Origene Technologies, Inc.
  • Pairwise Plants
  • Precision Bioscience, Inc.
  • Sangamo Therapeutics Inc.
  • Thermo Fisher Scientific, Inc.
  • Transposagen Biopharmaceuticals, Inc.
  • Tropic Biosciences UK LTD.
  • Yield10 Bioscience, Inc.
Note: Product cover images may vary from those shown